544 patents currently held
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
66
Ending by 2030
Jan 2027
Next term end
331
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2031 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends Apr 2035 · High confidence
Assay Systems for Determination of Source Contribution in a Sample
US 10,308,981
The most cited patent in this portfolio, cited by 303 later US patents, top 1% of utility patents granted in 2019 in our data. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Integrated Multiplex Target Analysis
US 9,957,553
Cited by 139 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Cartridge for Performing Assays in a Closed Sample Preparation and Reaction System
US 9,598,722
Cited by 64 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 5 fees due Dec 4 to 30, 2026 · next Dec 4
- 12 fees due Jan 14 to 28, 2027 · next Jan 14
- 17 fees due Feb 6 to 28, 2027 · next Feb 6
- 8 fees due Mar 12 to 26, 2027 · next Mar 12
- 7 fees due Apr 3 to 24, 2027 · next Apr 3
- 4 fees due May 3 to 26, 2027 · next May 3
- 7 fees due Jun 3 to 29, 2027 · next Jun 3
- 11 fees due Jul 2 to 28, 2027 · next Jul 2
- 8 fees due Aug 16 to 27, 2027 · next Aug 16
- 13 fees due Sep 1 to 29, 2027 · next Sep 1
- 7 fees due Oct 7 to 26, 2027 · next Oct 7
- 4 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- Nov 11Assignment recorded on 1 record: Roche Diagnostics International AG to Roche Molecular Systems, Inc. Recorded Nov 11, 2026, executed Sep 25, 2018. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76720, frame 949.
- Oct 22Assignment recorded on 1 record: Sankarlingam, Victor Sundaram and 1 other to Roche Molecular Systems, Inc. Recorded Oct 22, 2026, executed Jul 16, 2024. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76474, frame 744.
- 10 of the patents on this record were granted since Aug 17, 2026
- 3 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 331 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Assay Systems for Genetic Analysis | 26 in force | to Jul 2035 |
| Informatics Platform for Integrated Clinical Care | 9 in force | to May 2038 |
| Integrated Multiplex Target Analysis | 8 in force | to Oct 2035 |
| Systems and Methods for Assessing Electrical Connectivity Between Elements of Assay Devices | 5 in force | to Oct 2038 |
| Non-Replicative Transduction Particles and Transduction Particle-Based Reporter Systems | 5 in force | to Mar 2034 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,919,242 | Light Emission Modifiers and Their Uses in Nucleic Acid Detection, Amplification and Analysis In force · High confidence | In force | High confidence | |
| US 7,691,571 | Detection of Bordetella In force · High confidence | In force | High confidence | |
| US 7,668,663 | Levenberg-Marquardt Outlier Spike Removal Method In force · High confidence | In force | High confidence | |
| US 8,936,933 | Sample Processing Methods In force · Medium confidence | In force | Medium confidence | |
| US 7,989,169 | Selective Amplification of Methylated Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,453,842 | Inhibition of Peroxidase Enzymatic Activity In force · High confidence | In force | High confidence | |
| US 8,735,083 | Inhibition of Peroxidase Enzymatic Activity In force · High confidence | In force | High confidence | |
| US 7,680,604 | PCR Elbow Determination by Rotational Transform After Zero Slope Alignment In force · Medium confidence | In force | Medium confidence | |
| US 7,482,939 | Electrical Drop Surveillance In force · High confidence | In force | High confidence | |
| US 10,035,993 | DNA Polymerases and Related Methods In force · High confidence | In force | High confidence |
Also on record, not counted in the 544: 27 patents in force now held by others · 131 patents ended · 93 applications pending · 227 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.